Honkuwa Pharmaceutical Co. has reached a strategic alliance agreement with Professor Yoshiki Sawa, a member of the Japan Academy of Engineering, a world-leading expert in the field of regenerative medicine, and has appointed Professor Yoshiki Sawa as the Honorary Chief R&D Scientist of Honkuwa Pharmaceutical. The two companies held a signing ceremony in Osaka, marking a new chapter in innovative drug development together.

The purpose of this collaboration is to combine Professor Yoshiki Sawa's excellent research in the fields of cell biology and regenerative medicine with the development capabilities of Honkuwa Pharmaceutical's cutting-edge products to promote the development of innovative treatment solutions in the fields of repair of joint and muscle injuries.

"I have been engaged in research and clinical applications in the field of regenerative science for many years, and I hope that we can improve the health of more patients by closely linking cutting-edge science and technology in this field with Honkuwa Pharmaceutical's products, and exploring ways to better apply science and technology to clinical practice', said Professor Yoshiki Sawa.